ITRM990338A0 - Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria. - Google Patents

Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria.

Info

Publication number
ITRM990338A0
ITRM990338A0 IT1999RM000338A ITRM990338A ITRM990338A0 IT RM990338 A0 ITRM990338 A0 IT RM990338A0 IT 1999RM000338 A IT1999RM000338 A IT 1999RM000338A IT RM990338 A ITRM990338 A IT RM990338A IT RM990338 A0 ITRM990338 A0 IT RM990338A0
Authority
IT
Italy
Prior art keywords
hyperoxaluria
dietary
prevention
treatment
pharmaceutical composition
Prior art date
Application number
IT1999RM000338A
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Mendes S U R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mendes S U R L filed Critical Mendes S U R L
Publication of ITRM990338A0 publication Critical patent/ITRM990338A0/it
Priority to IT1999RM000338A priority Critical patent/IT1309427B1/it
Priority to CZ20014076A priority patent/CZ20014076A3/cs
Priority to TR2001/03439T priority patent/TR200103439T2/xx
Priority to KR1020017014857A priority patent/KR100781703B1/ko
Priority to PL00352014A priority patent/PL352014A1/xx
Priority to CA002373255A priority patent/CA2373255C/en
Priority to NZ516020A priority patent/NZ516020A/xx
Priority to CNB008081824A priority patent/CN100350919C/zh
Priority to BRPI0011038-8A priority patent/BR0011038B1/pt
Priority to EEP200100618A priority patent/EE200100618A/xx
Priority to IL14670300A priority patent/IL146703A0/xx
Priority to PT00935478T priority patent/PT1181027E/pt
Priority to DZ003165A priority patent/DZ3165A1/xx
Priority to JP2000620965A priority patent/JP4737836B2/ja
Priority to AU51016/00A priority patent/AU773459B2/en
Priority to HU0201409A priority patent/HU225134B1/hu
Priority to ES00935478T priority patent/ES2219344T3/es
Priority to DK00935478T priority patent/DK1181027T3/da
Priority to SI200030363T priority patent/SI1181027T1/xx
Priority to HK03100152.1A priority patent/HK1048066B/zh
Priority to SK1661-2001A priority patent/SK16612001A3/sk
Priority to AT00935478T priority patent/ATE265857T1/de
Priority to EA200101262A priority patent/EA004257B1/ru
Priority to PCT/IT2000/000213 priority patent/WO2000072855A2/en
Priority to UA2001129040A priority patent/UA71621C2/uk
Priority to ARP000102552A priority patent/AR024555A1/es
Priority to EP00935478A priority patent/EP1181027B1/en
Priority to MXPA01012184A priority patent/MXPA01012184A/es
Priority to DE60010456T priority patent/DE60010456T2/de
Publication of ITRM990338A1 publication Critical patent/ITRM990338A1/it
Priority to IS6150A priority patent/IS6150A/is
Priority to MA26402A priority patent/MA26790A1/fr
Priority to IL146703A priority patent/IL146703A/en
Priority to US09/992,029 priority patent/US6562336B2/en
Priority to NO20015782A priority patent/NO20015782L/no
Priority to ZA200110504A priority patent/ZA200110504B/xx
Application granted granted Critical
Publication of IT1309427B1 publication Critical patent/IT1309427B1/it
Priority to US11/050,623 priority patent/USRE39585E1/en
Priority to IL199437A priority patent/IL199437A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
IT1999RM000338A 1999-05-28 1999-05-28 Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso IT1309427B1 (it)

Priority Applications (37)

Application Number Priority Date Filing Date Title
IT1999RM000338A IT1309427B1 (it) 1999-05-28 1999-05-28 Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
SI200030363T SI1181027T1 (en) 1999-05-28 2000-05-24 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
HK03100152.1A HK1048066B (zh) 1999-05-28 2000-05-24 用於预防或治疗尿草酸盐过多的膳食或药物组合物
KR1020017014857A KR100781703B1 (ko) 1999-05-28 2000-05-24 과옥살산뇨증의 예방 또는 치료에 사용하기 위한 식이성또는 약학 조성물
PL00352014A PL352014A1 (en) 1999-05-28 2000-05-24 Dietetic of pharmacological composition for preventing or treating hyperoxaluria
CA002373255A CA2373255C (en) 1999-05-28 2000-05-24 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
NZ516020A NZ516020A (en) 1999-05-28 2000-05-24 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
CNB008081824A CN100350919C (zh) 1999-05-28 2000-05-24 用于预防或治疗尿草酸盐过多的膳食或药物组合物
BRPI0011038-8A BR0011038B1 (pt) 1999-05-28 2000-05-24 Uso de uma composição de combinação bacteriana na prevenção e/ou tratamento de hiperoxalúria e dos disturbios associados com esta e composição de combinação bacteriana alimentícia/farmacêutica
EEP200100618A EE200100618A (et) 1999-05-28 2000-05-24 Dieet- või farmatseutiline kompositsioon kasutamiseks hüperoksaluuria vältimiseks või raviks
IL14670300A IL146703A0 (en) 1999-05-28 2000-05-24 Dietary of pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
PT00935478T PT1181027E (pt) 1999-05-28 2000-05-24 Composicao dietetica ou farmaceutica para utilizacao na prevencao ou tratamento de hiperoxaluria
DZ003165A DZ3165A1 (fr) 1999-05-28 2000-05-24 Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.
JP2000620965A JP4737836B2 (ja) 1999-05-28 2000-05-24 高シュウ酸尿症の予防または処置用の食養生または医薬組成物
AU51016/00A AU773459B2 (en) 1999-05-28 2000-05-24 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
HU0201409A HU225134B1 (en) 1999-05-28 2000-05-24 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
ES00935478T ES2219344T3 (es) 1999-05-28 2000-05-24 Composicion dietetica o farmaceutica para su uso en la prevencion o el tratamiento de la hiperoxaluria.
TR2001/03439T TR200103439T2 (tr) 1999-05-28 2000-05-24 Hiperoksalürinin önlenmesi veya tedavisi amaçlı kullanılmak üzere diyet.
CZ20014076A CZ20014076A3 (cs) 1999-05-28 2000-05-24 Dietní nebo farmaceutické přípravky pro pouľití k prevenci nebo léčbě hyperoxalurie
SK1661-2001A SK16612001A3 (sk) 1999-05-28 2000-05-24 Diétny alebo farmaceutický prostriedok na použitie pri prevencii alebo liečbe hyperoxalúrie
DK00935478T DK1181027T3 (da) 1999-05-28 2000-05-24 Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri
UA2001129040A UA71621C2 (en) 1999-05-28 2000-05-24 Use of combined bacterial composition as dietary or pharmaceutical supplement for preventing or treating hyperoxaluria
EA200101262A EA004257B1 (ru) 1999-05-28 2000-05-24 Применение бактериальной комбинированной композиции для получения средства для профилактики и/или лечения гипероксалурии у людей и животных и способ профилактики и/или лечения указанного заболевания
PCT/IT2000/000213 WO2000072855A2 (en) 1999-05-28 2000-05-24 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
AT00935478T ATE265857T1 (de) 1999-05-28 2000-05-24 Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
ARP000102552A AR024555A1 (es) 1999-05-28 2000-05-24 Composicion dietaria o farmaceutica para ser utilizada en la prevencion o tratamiento de la hiperoxaluria
EP00935478A EP1181027B1 (en) 1999-05-28 2000-05-24 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
MXPA01012184A MXPA01012184A (es) 1999-05-28 2000-05-24 Composicion dietetica o farmaceutica para utilizarse en la prevencion o tratamiento de la hiperoxaluria.
DE60010456T DE60010456T2 (de) 1999-05-28 2000-05-24 Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
IS6150A IS6150A (is) 1999-05-28 2001-11-08 Næringar- eða lyfjasamsetningar til nota við fyrirbyggingu eða meðhöndlun á ofurkalsíum oxalat myndun
MA26402A MA26790A1 (fr) 1999-05-28 2001-11-08 Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie
IL146703A IL146703A (en) 1999-05-28 2001-11-22 Dietary or pharmaceutical composition comprising streptococcus thermophilus and lactobacillus brevis and its use for the prevention or treatment of hyperoxaluria
US09/992,029 US6562336B2 (en) 1999-05-28 2001-11-26 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
NO20015782A NO20015782L (no) 1999-05-28 2001-11-27 Kostblanding eller farmasöytisk sammensetning til anvendelse for forebyggelse eller behandling av hyperoksaluri
ZA200110504A ZA200110504B (en) 1999-05-28 2001-12-21 Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria.
US11/050,623 USRE39585E1 (en) 1999-05-28 2005-02-04 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
IL199437A IL199437A (en) 1999-05-28 2009-06-18 Using at least one strain of bacteria to make a dietetic and / or pharmacist's medicine for the prevention or treatment of hypoxular disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000338A IT1309427B1 (it) 1999-05-28 1999-05-28 Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso

Publications (3)

Publication Number Publication Date
ITRM990338A0 true ITRM990338A0 (it) 1999-05-28
ITRM990338A1 ITRM990338A1 (it) 2000-11-28
IT1309427B1 IT1309427B1 (it) 2002-01-23

Family

ID=11406789

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999RM000338A IT1309427B1 (it) 1999-05-28 1999-05-28 Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso

Country Status (34)

Country Link
US (2) US6562336B2 (it)
EP (1) EP1181027B1 (it)
JP (1) JP4737836B2 (it)
KR (1) KR100781703B1 (it)
CN (1) CN100350919C (it)
AR (1) AR024555A1 (it)
AT (1) ATE265857T1 (it)
AU (1) AU773459B2 (it)
BR (1) BR0011038B1 (it)
CA (1) CA2373255C (it)
CZ (1) CZ20014076A3 (it)
DE (1) DE60010456T2 (it)
DK (1) DK1181027T3 (it)
DZ (1) DZ3165A1 (it)
EA (1) EA004257B1 (it)
EE (1) EE200100618A (it)
ES (1) ES2219344T3 (it)
HK (1) HK1048066B (it)
HU (1) HU225134B1 (it)
IL (3) IL146703A0 (it)
IS (1) IS6150A (it)
IT (1) IT1309427B1 (it)
MA (1) MA26790A1 (it)
MX (1) MXPA01012184A (it)
NO (1) NO20015782L (it)
NZ (1) NZ516020A (it)
PL (1) PL352014A1 (it)
PT (1) PT1181027E (it)
SI (1) SI1181027T1 (it)
SK (1) SK16612001A3 (it)
TR (1) TR200103439T2 (it)
UA (1) UA71621C2 (it)
WO (1) WO2000072855A2 (it)
ZA (1) ZA200110504B (it)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
US8486389B2 (en) * 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
US20050074442A1 (en) * 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
US9655932B2 (en) 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
EP1649863A1 (en) * 2003-06-24 2006-04-26 Otsuka Pharmaceutical Co., Ltd. Composition for lowering serum uric acid level
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
WO2005089564A1 (en) 2004-03-19 2005-09-29 Danisco A/S Emulsifier composition for shortening
US7468182B2 (en) * 2004-10-27 2008-12-23 North Carolina State University Lactobacillus acidophilus nucleic acids and uses thereof
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
EP2261323A1 (en) 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
WO2007070052A2 (en) * 2005-12-14 2007-06-21 Oxthera, Inc. Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
JP5558002B2 (ja) 2005-12-16 2014-07-23 オクセラ インコーポレイテッド シュウ酸塩低減化のための組成物および方法
US20080241226A1 (en) * 2007-03-27 2008-10-02 Abeln Susan L Methods and Kits For Administering Probiotics
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CN101606952B (zh) * 2008-06-17 2012-09-19 上海交通大学医学院附属第三人民医院 乳双歧杆菌在制备预防泌尿系统结石药物中的应用
US9283252B2 (en) 2008-09-30 2016-03-15 Meiji Co., Ltd. Lactic acid bacterium having high oxalic acid decomposition ability
CN101554237B (zh) * 2009-03-16 2013-11-06 武汉康复得生物科技有限公司 植物纤维或微生物不溶组分中的草酸降解酶的制备方法
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
ITMI20121173A1 (it) * 2012-07-04 2014-01-05 Neupharma Srl Composizioni dietetiche e/o farmaceutiche comprendenti ceppi di lactobacillus e bifidobacterium capaci di degradare gli ossalati e di indurre una risposta immunitaria di tipo anti-infiammatorio
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
JP5765832B2 (ja) * 2013-12-26 2015-08-19 雪印メグミルク株式会社 加齢に伴う代謝異常症の予防・改善・治療剤
CA2963213C (en) * 2014-10-01 2021-02-09 Triphase Pharmaceuticals Pvt. Ltd. Thermo-stable lactobacillus strains, products and methods thereof
ITUB20155752A1 (it) 2015-11-19 2017-05-19 Probiotical Spa Composizione di batteri per uso per attenuare le diminuzioni di prestazione dopo un esercizio fisico che danneggia i muscoli.
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
CN107868776A (zh) 2016-09-23 2018-04-03 武汉康复得生物科技股份有限公司 糖基化草酸脱羧酶及其制备和应用
US11179426B2 (en) 2016-12-29 2021-11-23 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
US12421518B2 (en) 2018-12-10 2025-09-23 Tenza, Inc. Methods and compositions for treating hyperoxaluria
BR112022013867A2 (pt) * 2020-01-14 2022-09-13 Synlogic Operating Co Inc Bactérias manipuladas para tratar distúrbios nos quais o oxalato é prejudicial
CN113308416B (zh) * 2021-07-20 2023-02-24 四川大学 一株具有抑制肾结石形成能力的植物乳杆菌及其应用
CN115851508B (zh) * 2022-10-13 2024-01-09 山东中科嘉亿生物工程有限公司 一种降草酸、改善肾结石的嗜热链球菌jyst-26及其产品、应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5810520A (ja) * 1981-07-10 1983-01-21 Miyarisan Kk 胆石症の治療薬
DE69219768T2 (de) * 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
ATE169456T1 (de) * 1996-12-23 1998-08-15 Sitia Yomo Spa Lyophilisierte, lebende bakerien enthaltende nahrungszusammensetzung
JP4996780B2 (ja) * 1997-05-23 2012-08-08 オクセラ インコーポレイテッド シュウ酸塩関連疾患を予防するためのシュウ酸塩分解微生物またはシュウ酸塩分解酵素
RU2139346C1 (ru) * 1999-03-02 1999-10-10 Шендеров Борис Аркадьевич Штамм бактерий lactobacillus plantarum, обладающий способностью снижать уровень оксалата и используемый для приготовления препаратов и продуктов питания для профилактики и лечения гипероксалурии

Also Published As

Publication number Publication date
WO2000072855A3 (en) 2001-06-28
CA2373255C (en) 2010-01-19
HK1048066A1 (zh) 2003-03-21
KR100781703B1 (ko) 2007-12-03
US6562336B2 (en) 2003-05-13
IT1309427B1 (it) 2002-01-23
ES2219344T3 (es) 2004-12-01
CA2373255A1 (en) 2000-12-07
NZ516020A (en) 2003-06-30
EE200100618A (et) 2003-02-17
SI1181027T1 (en) 2004-08-31
PT1181027E (pt) 2004-09-30
IL199437A0 (en) 2011-07-31
BR0011038A (pt) 2002-02-26
DK1181027T3 (da) 2004-08-16
JP2003500451A (ja) 2003-01-07
DZ3165A1 (fr) 2000-12-07
HU225134B1 (en) 2006-06-28
UA71621C2 (en) 2004-12-15
TR200103439T2 (tr) 2002-06-21
BR0011038B1 (pt) 2014-02-18
ATE265857T1 (de) 2004-05-15
MXPA01012184A (es) 2003-06-30
SK16612001A3 (sk) 2002-04-04
KR20020019918A (ko) 2002-03-13
WO2000072855A2 (en) 2000-12-07
EA004257B1 (ru) 2004-02-26
USRE39585E1 (en) 2007-04-24
JP4737836B2 (ja) 2011-08-03
IS6150A (is) 2001-11-08
EA200101262A1 (ru) 2002-04-25
DE60010456D1 (de) 2004-06-09
EP1181027B1 (en) 2004-05-06
AU773459B2 (en) 2004-05-27
HUP0201409A3 (en) 2004-10-28
AU5101600A (en) 2000-12-18
DE60010456T2 (de) 2005-05-12
IL199437A (en) 2016-10-31
CN100350919C (zh) 2007-11-28
IL146703A0 (en) 2002-07-25
US20020061292A1 (en) 2002-05-23
HUP0201409A2 (en) 2002-08-28
AR024555A1 (es) 2002-10-16
NO20015782L (no) 2002-01-25
CN1365284A (zh) 2002-08-21
ZA200110504B (en) 2002-09-25
IL146703A (en) 2010-03-28
CZ20014076A3 (cs) 2002-03-13
MA26790A1 (fr) 2004-12-20
PL352014A1 (en) 2003-07-14
HK1048066B (zh) 2008-08-01
ITRM990338A1 (it) 2000-11-28
EP1181027A2 (en) 2002-02-27
NO20015782D0 (no) 2001-11-27

Similar Documents

Publication Publication Date Title
ITRM990338A0 (it) Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria.
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
HUP0303148A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing the compounds and processes for their preparation
EE04578B1 (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nendesolvaatide suu kaudu manustamiseks
HUP0401567A3 (en) Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them
NO20042739L (no) Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
EE200200281A (et) Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks
NO20035035D0 (no) Citrasalt av 5,8,14-triazatetracyklo (10.3.1.0 opphöyet 2,11 .0 opphöyet 4,9) - heksadeca-2. (11), 3,5,7,9-pentaen og farmasöytiskesammensetninger derav
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
HUP0001104A2 (hu) Ibuprofent és domperidont tartalmazó készítmények migrén kezelésére
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
EP1537875A4 (en) MEANS FOR THE PREVENTION / TREATMENT OF ARTERIOSCLEROSIS
IT1306179B1 (it) Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
ITRM990707A0 (it) Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil l-carni
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
ITMI20011284A0 (it) Composizione farmaceutica per il trattamento dell'iperfosfatemia
ITRM20000106A0 (it) Composizione per la prevenzione e/o il trattamento di vascolopatie, che comprende propionil l-carnitina e coenzima q10.
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia
ITMI20011378A0 (it) Composizione farmaceutica per il trattamento dell'iperfosfatemia
IT1306143B1 (it) Composizione per la prevenzione ed il trattamento delle alterazionimentali e comportamentali.
ITTO20001109A0 (it) Composizione farmaceutica per il trattamento anti m. ulcerans.
IL127102A0 (en) Pharmaceutical compositions for the treatment of dyskinesias
ITRM20000688A0 (it) Uso della isovaleril l-carnitina per la preparazione di un medicamento per la prevenzione e cura dell'osteoporosi.
SI1207878T1 (en) Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof